SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

ZUCCHINI, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.685
AS - Asia 3.743
EU - Europa 3.015
SA - Sud America 518
AF - Africa 91
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 15.061
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.477
SG - Singapore 1.361
CN - Cina 990
PL - Polonia 682
VN - Vietnam 431
DE - Germania 419
RU - Federazione Russa 412
BR - Brasile 390
IT - Italia 376
UA - Ucraina 293
GB - Regno Unito 248
HK - Hong Kong 242
TR - Turchia 204
FI - Finlandia 196
BD - Bangladesh 156
FR - Francia 128
CA - Canada 120
JP - Giappone 90
IN - India 82
SE - Svezia 56
AR - Argentina 50
MX - Messico 50
ES - Italia 39
ID - Indonesia 39
ZA - Sudafrica 35
IQ - Iraq 33
NL - Olanda 29
CZ - Repubblica Ceca 28
AT - Austria 27
PK - Pakistan 24
EC - Ecuador 22
LT - Lituania 19
CO - Colombia 17
MA - Marocco 16
VE - Venezuela 16
BE - Belgio 14
CL - Cile 12
SA - Arabia Saudita 12
AE - Emirati Arabi Uniti 10
JM - Giamaica 8
PH - Filippine 8
AU - Australia 7
EG - Egitto 7
IR - Iran 7
JO - Giordania 7
KE - Kenya 7
PT - Portogallo 7
UZ - Uzbekistan 7
DO - Repubblica Dominicana 6
ET - Etiopia 6
HN - Honduras 6
MY - Malesia 6
CH - Svizzera 5
DZ - Algeria 5
PA - Panama 5
RS - Serbia 5
BY - Bielorussia 4
GT - Guatemala 4
IL - Israele 4
NP - Nepal 4
RO - Romania 4
TN - Tunisia 4
UY - Uruguay 4
AZ - Azerbaigian 3
CR - Costa Rica 3
GE - Georgia 3
GR - Grecia 3
IE - Irlanda 3
KR - Corea 3
LB - Libano 3
NI - Nicaragua 3
OM - Oman 3
PY - Paraguay 3
SI - Slovenia 3
AL - Albania 2
AM - Armenia 2
BG - Bulgaria 2
BH - Bahrain 2
CI - Costa d'Avorio 2
DK - Danimarca 2
KZ - Kazakistan 2
MD - Moldavia 2
NO - Norvegia 2
PE - Perù 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BS - Bahamas 1
DM - Dominica 1
EE - Estonia 1
GN - Guinea 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MN - Mongolia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
Totale 15.052
Salva come PNG Salva come JPEG
Città #
Ashburn 1.008
Singapore 868
Fairfield 683
Warsaw 670
Woodbridge 645
San Jose 532
Houston 395
Beijing 368
Chandler 343
Jacksonville 314
Santa Clara 296
Seattle 264
Ann Arbor 256
Wilmington 243
Hong Kong 240
Munich 204
Cambridge 198
New York 155
Los Angeles 151
Ho Chi Minh City 135
Ferrara 113
Hanoi 108
Nanjing 106
Izmir 104
Helsinki 100
Dallas 90
Tokyo 89
Council Bluffs 72
Princeton 71
Milan 59
San Diego 59
Shanghai 56
Lauterbourg 55
Orem 54
São Paulo 43
Boardman 41
Buffalo 39
Washington 39
Brooklyn 34
London 33
Montreal 32
Turku 31
Chicago 29
Jakarta 29
Toronto 29
Chennai 28
Denver 28
Frankfurt am Main 28
Phoenix 28
Boston 25
Mexico City 25
Nanchang 25
Atlanta 24
Bologna 23
Da Nang 22
Stockholm 22
Hebei 21
Johannesburg 21
Poplar 21
Moscow 19
San Francisco 19
Vienna 19
Falkenstein 18
Vancouver 18
Amsterdam 17
Brno 17
Jiaxing 17
Manchester 17
Norwalk 16
Shenyang 16
The Dalles 16
Rome 15
Auburn Hills 14
Dearborn 14
Haiphong 14
Hefei 14
Falls Church 13
Mcallen 13
Rio de Janeiro 13
Tianjin 13
Ankara 12
Baghdad 12
Montréal 12
Brussels 11
Mountain View 11
Nuremberg 11
Quito 11
Brasília 10
Bremen 10
Changsha 10
Columbus 10
Guangzhou 10
Mumbai 10
Hải Dương 9
Ningbo 9
San Mateo 9
Dong Ket 8
Guarulhos 8
Hangzhou 8
Istanbul 8
Totale 10.355
Salva come PNG Salva come JPEG
Nome #
Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats 638
Is autopsy tissue a valid control for epilepsy surgery tissue in microRNA studies? 413
Bystander effect on brain tissue of mesoangioblasts producing neurotrophins 397
MicroRNA profiles in hippocampal granule cells and plasma of rats with pilocarpine-induced epilepsy - Comparison with human epileptic samples 384
Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE Genes 379
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 319
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 272
FGF-2 Overexpression Increases Excitability and Seizure Susceptibility but Decreases Seizure-Induced Cell Loss 271
Personalized needles for microinjections in the rodent brain 248
A pathogenetic hypothesis of Unverricht-Lundborg disease onset and progression 247
Decreased levels of neuropeptide Y5 receptor binding sites in two experimental models of epilepsy 246
Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo 244
Alterations in seizure susceptibility and in seizure-induced plasticity after pharmacologic and genetic manipulation of the Fibroblast Growth Factor-2 system 244
Hippocampal FGF-2 and BDNF overexpression attenuates epileptogenesis-associated neuroinflammation and reduces spontaneous recurrent seizures. 243
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 230
Brain-derived neurotrophic factor mRNA and protein are targeted to discrete dendritic laminas by events that trigger epileptogenesis 228
Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex 224
Delayed epileptogenesis in nociceptin/orphanin FQ-deficient mice 219
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 218
Gene Therapy Tools for Brain Diseases 214
A potential reservoir of immature dopaminergic replacement neurons in the adult mammalian olfactory bulb 212
Dendritic targeting of mRNAs for plasticity genes in experimental models of temporal lobe epilepsy 211
Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model 210
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 210
Involvement of the neuropeptide nociceptin/orphanin FQ in kainate seizures 209
Fibroblast Growth Factor-2 (FGF-2). 208
Involvement of the neuropeptide orphanin FQ/nociceptin in kainate and kindling seizures and epileptogenesis 208
Effects of [Nphe(1), Arg(14), Lys(15)] N/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress 205
Antipsychotic drugs counteract autophagy and mitophagy in multiple sclerosis 205
Functional antagonism between nociceptin/orphanin FQ (N/OFQ) and corticotropin releasing factor (CRF) in the rat brain: evidence for involvement of the bed nucleus of the stria terminalis 202
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 202
Localized overexpression of FGF-2 and BDNF in hippocampus reduces mossy fiber sprouting and spontaneous seizures up to 4 weeks after pilocarpine-induced status epilepticus 201
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 198
Are the neurotrophic factors a suitable therapeutic target for the prevention of epileptogenesis? 197
A Matter of Genes: The Hurdles of Gene Therapy for Epilepsy 192
Properties and maturation of adult-generated dopaminergic neurons in the mammalian olfactory bulb 190
Implication of sestrin3 in epilepsy and its comorbidities 189
Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: New evidence from rats and mice 187
Temporal lobe epilepsy model, neural stem cells and gene therapy 185
Mechanisms of action of CHF3381 in the forebrain 184
Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread 183
Herpes Simplex Virus Type 1 (HSV-1) Uracil-DNA Glycosylase: Functional Expression in Escherichia coli, Biochemical Characterization, and Selective Inhibition by 6-(p-n-Octylanilino)Uracil 179
Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: Immunogenicity and protection in mice 177
Bradykinin B2 receptors increase hippocampal excitability and susceptibility to seizures in mice 174
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo 169
Pro-nociceptin/orphanin FQ and NOP receptor mRNA levels in the forebrain of food deprived rats 169
Dynorphin and Nociceptin/Orphanin FQ (N/OFQ). 168
Circulating microRNAs and isomiRs as biomarkers for the initial insult and epileptogenesis in four experimental epilepsy models: The EPITARGET study 163
Lack of Direct Effects of Neurotrophic Factors in an In Vitro Model of Neuroinflammation 159
Different patterns of induction of fibroblast growth factor-2 and brain-derived neurotrophic factor messenger RNAs during kindling epileptogenesis, and development of a herpes simplex vector for fibroblast growth factor-2 gene transfer in vivo 159
Sampling Cerebrospinal Fluid and Blood from Lateral Tail Vein in Rats during EEG Recordings 157
Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model 154
Increased susceptibility to kainate seizures and decreased seizure-induced cell loss in transgenic mice overexpressing fibroblast growth factor-2 153
HERPES-SIMPLEX VIRUS TYPE-1 URACIL-DNA GLYCOSYLASE - CLONING AND CHARACTERIZATION 151
Gene therapy for epilepsy targeting neuropeptide Y and its Y2 receptor to dentate gyrus granule cells 150
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 147
Brain interstitial nociceptin/orphanin FQ levels are elevated in Parkinson’s disease 146
The NLRP3 Inflammasome in Neurodegenerative Disorders: Insights from Epileptic Models 143
Low-dose 7,8-Dihydroxyflavone Administration After Status Epilepticus Prevents Epilepsy Development 139
Immunotherapeutic activity of a recombinant glycoprotein vaccine aganst recurrent genital herpes in a guinea pig model. 132
Impairment of GABA release in the hippocampus at the time of the first spontaneous seizure in the pilocarpine model of temporal lobe epilepsy 131
Improvement of HSV-1 based amplicon vectors for a safe and long-lasting gene therapy in non-replicating cells 129
Increased extracellular levels of glutamate in the hippocampus of chronically epileptic rats 126
Inhibition of human immunodeficiency virus reactivation from latency by tat antisense RNA and a tat transdominant negative mutant 125
Viral Vector-Based Gene Therapy for Epilepsy: What Does the Future Hold? 120
Gene therapy of the nervous system by herpes virus vectors 119
Increased excitability in tat-transgenic mice: role of tat in HIV-related neurological disorders 119
Molecular approaches to inhibit HIV-1 tat expression and functions 106
Identification of miRNAs differentially expressed in human epilepsy with or without granule cell pathology 98
null 97
Implication of fibroblast growth factors in epileptogenesis-associated circuit rearrangements. 97
Neuroprotective activity of CHF3381, a putative N-methyl-D-aspartate receptor antagonist 97
null 94
null 94
null 93
null 92
null 89
null 89
null 89
Possible Approaches of Gene Therapy of AIDS. 88
null 43
Totale 15.190
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.360
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.877
Totale 64.237
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022742 31 94 61 24 27 28 47 42 20 48 69 251
2022/2023734 74 44 48 75 119 101 38 77 100 4 40 14
2023/2024881 41 46 41 12 48 222 89 97 66 62 50 107
2024/20252.055 55 47 152 114 215 264 86 109 324 157 253 279
2025/20265.692 654 194 397 756 830 416 699 274 498 522 301 151
2026/2027123 123 0 0 0 0 0 0 0 0 0 0 0
Totale 15.190